[Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice].

@article{Koric2011UseOC,
  title={[Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice].},
  author={Lejla Koric and Olivier Felician and Mathieu Ceccaldi},
  journal={Revue neurologique},
  year={2011},
  volume={167 6-7},
  pages={474-84}
}
INTRODUCTION The diagnosis of Alzheimer's disease (AD) currently relies on clinical criteria that are primarily based on the presence of an amnestic syndrome of the mesial temporal lobe type. In recent years, new diagnostic tools have been developed, such as the possibility of measuring a set of proteins directly involved in the pathophysiological process… CONTINUE READING